Alzheimer's Disease - Endocannabinoid System Study
A Study of the Endocannabinoid System in Alzheimer's Disease
Protocol ID
05.04.140
Protocol Description
The purpose of this study is to collect DNA (genetic material) from people to study factors, which influence the development of memory disorders. The investigators will study DNA (the genetic material inherited from your parents) samples from people with memory disorders and unrelated healthy individuals.
The investigators will examine the DNA for differences or similarities between individual subjects and investigate whether these differences or similarities are associated with the development of memory disorders. This study does not involve any treatment.
Eligibility Criteria
Patients diagnosed with memory disorders and healthy controls
Primary Investigator(s)
- Jeremy Koppel, MD